These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

385 related articles for article (PubMed ID: 29126817)

  • 41. Serum Antibody and Glomerular Antigen of Antiphospholipase A2 Receptor in Chinese Patients with Idiopathic Membranous Nephropathy.
    Zhang QH; Wu M; Hu ZG; Liu XB; Huang B; Zhang Y; Liu B; Zhu YS; Wang L; Sun ZX
    Biomed Res Int; 2020; 2020():1693710. PubMed ID: 32461964
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The relationship of anti-phospholipase A2 receptor antibody and C5a complement with disease activity and short-term outcome in idiopathic membranous nephropathy.
    Chi JN; Lai TS; Wu CF; Fu TY; Chou YH; Chiu YL; Lin WC; Chiang WC; Chen YM; Wu MS
    J Formos Med Assoc; 2019 May; 118(5):898-906. PubMed ID: 30639075
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clinical value of renal phospholipase A2 receptor deposit in the prognosis evaluation and treatment options of idiopathic membranous nephropathy: A retrospective cohort study.
    Xie Z; Dong W; Li Z; Chen Y; Song L; Li R; Wu Y; Fu L; Liang H; Tao Y; Xie J; Wang W; Liu S; Ye Z; Shi W; Liang X
    Nephrology (Carlton); 2020 Mar; 25(3):219-229. PubMed ID: 31900967
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Circulating anti-phospholipase A2 receptor antibodies as a diagnostic and prognostic marker in Greek patients with idiopathic membranous nephropathy - a retrospective cohort study.
    Provatopoulou S; Kalavrizioti D; Stangou M; Kouri MN; Kalliakmani P; Papasotiriou M; Papachristou E; Goumenos DS; Papagianni A
    Rom J Intern Med; 2019 Jun; 57(2):141-150. PubMed ID: 30864406
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Antibodies to M-type phospholipase A2 receptor (PLA
    Garcia-Vives E; Solé C; Moliné T; Alvarez-Rios AM; Vidal M; Agraz I; Ordi-Ros J; Cortés-Hernández J
    Lupus; 2019 Mar; 28(3):396-405. PubMed ID: 30760090
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Enhanced expression of the M-type phospholipase A2 receptor in glomeruli correlates with serum receptor antibodies in primary membranous nephropathy.
    Hoxha E; Kneißler U; Stege G; Zahner G; Thiele I; Panzer U; Harendza S; Helmchen UM; Stahl RA
    Kidney Int; 2012 Oct; 82(7):797-804. PubMed ID: 22673885
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The correlation between anti-phospholipase A2 receptor antibodies and hypercoagulability in patients with idiopathic membranous nephropathy.
    Liu Y; Tang Y; Le WB; Chen D; Liang D; Xu F; Liang S; Zhong Y; Zeng C
    Ren Fail; 2024 Dec; 46(2):2374448. PubMed ID: 38973428
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The diagnosis accuracy of PLA2R-AB in the diagnosis of idiopathic membranous nephropathy: a meta-analysis.
    Du Y; Li J; He F; Lv Y; Liu W; Wu P; Huang J; Wei S; Gao H
    PLoS One; 2014; 9(8):e104936. PubMed ID: 25136841
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Association of anti-PLA₂R antibodies with outcomes after immunosuppressive therapy in idiopathic membranous nephropathy.
    Bech AP; Hofstra JM; Brenchley PE; Wetzels JF
    Clin J Am Soc Nephrol; 2014 Aug; 9(8):1386-92. PubMed ID: 25035272
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Phospholipase A2 Receptor Autoantibodies as a Novel Serological Biomarker for Autoimmune Thyroid Disease Associated Nephropathy.
    Huang B; Zhang Y; Wang L; Wu Q; Li T; Zhang J; Zhang Q; Sheng H; Bao J; Hu Z
    Front Immunol; 2020; 11():837. PubMed ID: 32425952
    [No Abstract]   [Full Text] [Related]  

  • 51. Diagnostic accuracy of PLA2R autoantibodies and glomerular staining for the differentiation of idiopathic and secondary membranous nephropathy: an updated meta-analysis.
    Dai H; Zhang H; He Y
    Sci Rep; 2015 Mar; 5():8803. PubMed ID: 25740009
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Response to immunosuppressive therapy in PLA
    Wang J; Xie Q; Sun Z; Xu N; Li Y; Wang L; Liu S; Xue J; Hao CM
    BMC Nephrol; 2017 Jul; 18(1):227. PubMed ID: 28693446
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Association of anti-phospholipasea2-receptor antibodies with clinical course of idiopathic membranous nephropathy.
    Thokhonelidze I; Maglakelidze N; Sarishvili N; Kasradze T; Dalakishvili K
    Georgian Med News; 2015 Apr; (241):49-53. PubMed ID: 25953939
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Phospholipase A2 Receptor Antibody IgG4 Subclass Improves Sensitivity and Specificity in the Diagnosis of Idiopathic Membranous Nephropathy.
    Huang B; Zhang Y; Wang L; Xu W; Zhang J; Zhang Q; Sheng H; Hu Z
    Kidney Blood Press Res; 2019; 44(4):848-857. PubMed ID: 31242492
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Analysis of Glomerular IgG Subclasses Switch in Idiopathic Membranous Nephropathy Classified by Glomerular Phospholipase A2 Receptor Antigen and Serum Antibody.
    Cui HY; Li C; Li H; Wen YB; Duan L; Li Y; Yan XW; Hu YT; Chen LM; Li XM
    Dis Markers; 2021; 2021():9965343. PubMed ID: 34497677
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Detection and clinical significance of glomerular M-type phospholipase A
    Liu H; Luo W; Gong S; Ding X
    Intern Med J; 2016 Nov; 46(11):1318-1322. PubMed ID: 27554390
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Clinicopathological features of atypical membranous nephropathy with unknown etiology in adult Chinese patients.
    Jiang Z; Cai M; Dong B; Yan Y; Yang B; Wang M; Wang Y; Li X; Lian L; Li S; Zuo L
    Medicine (Baltimore); 2018 Aug; 97(32):e11608. PubMed ID: 30095619
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Preliminary results of research on a new marker of idiopathic membranous nephropathy: anti-PLA2R].
    Kozioł M; Sikora A; Kozioł-Montewka M; Smarz-Widelska I; Orłowska-Kowalik G; Pyszna W; Załuska W; Ksiazek A
    Pol Merkur Lekarski; 2014 Mar; 36(213):171-4. PubMed ID: 24779214
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A comparison of clinical features between idiopathic membranous nephropathy patients with and without serum antibody against phospholipase A2 receptor.
    Zhang Q; Liu X; Zhang Z; Wu M; Huang B; Zhang Y; Liu B; Qi Z; Shan W; Wang L; Hu Z; Sun Z
    Medicine (Baltimore); 2019 Nov; 98(45):e17658. PubMed ID: 31702617
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The association of anti-PLA2R with clinical manifestations and outcomes in idiopathic membranous nephropathy: a meta-analysis.
    Rao SJ; Shen Q; Wang HM; Tang S; Wang XY
    Int Urol Nephrol; 2020 Nov; 52(11):2123-2133. PubMed ID: 32767251
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.